heartbase, Inc.’s Post

🔍 Exploring Retrograde Insertion of IVC Filter: A Crucial Bailout Plan In the realm of vascular interventions, the retrograde insertion of an Inferior Vena Cava (IVC) filter emerges as a strategic bailout plan, offering physicians a valuable tool in critical scenarios. 🚑 🔖 Read more at https://lnkd.in/dAKruxhr. 👥 Have you encountered cases where retrograde IVC filter insertion played a pivotal role? Share your experiences and insights. #VascularIntervention #IVCFilter #MedicalInnovation

Tune in tomorrow for updates on the latest technologies in #InterventionalCardiology! This webinar will equip you with a deep understanding of the CCTA + FFRCT pathway so you can assess its benefits and clinical impact. ➡️There is still time to register: https://lnkd.in/gyQ5ZAgM

Another guideline update from the ESC after last weekend’s annual congress, this one regarding functional assessment during intracoronary angiography. ESC has has upgraded FFR/iFR to a IA clinical recommendation, and Pd/Pa/dPR as a IIB alternative. The new guidelines describe a stepwise approach for chronic coronary syndrome. https://buff.ly/3MB0XN8 Using our RXi® System and Navvus® II MicroCatheter with the ACIST dPR upgrade, you have the option to implement both approaches mentioned above, all with your 0.014” guidewire of choice. https://buff.ly/4dQGhwn

Exploring Cardiogenic Shock Treatment with Multi-Device Simulation #ComputationalLife In our latest breakthrough, we've digitally replicated a patient in the throes of cardiogenic shock to assess the efficacy of four distinct medical devices. Our visual graphs do more than just depict left ventricular volumes during a cardiac cycle – they provide critical insights that guide physicians towards the most impactful treatment options. The evidence is clear and corroborated by literature: pVADs effectively reduce End-Diastolic Volume (EDV) without significantly affecting End-Systolic Volume (ESV). IABP optimally decreases both EDV and ESV, improving cardiac function. LVADs, with their unique triangular volume profiles, substantially reduce the overall volume in the left ventricle. ECMO, specifically from the right atrium to the femoral artery, increases both ESV and EDV. These simulations are more than data – they are the future of personalized patient care, offering a window into the real-time impact of life-saving interventions. Delve into the intricacies of our pioneering research and be part of the conversation shaping the future of cardiac care. For continuous updates and insights, make sure to follow our LinkedIn page. #DigitalHealth #CardiogenicShock #MedicalSimulation #HealthcareInnovation #IABP #pVAD #LVAD #ECMO #CardiacCare

Computational Life's simulation work on Cardiogenic Shock treatments showcases groundbreaking approaches to healthcare. Our insights into device efficacy illuminate paths to personalized care, proving how technology can transform patient outcomes. A fascinating glimpse into the power of medical simulations. #HealthTech #FutureOfMedicine

What do you do when a patient is in VT Storm with Polymorphic VT and VF? Salazar, et al. outline a stepwise protocol for a strategic approach. Glenn Dym, MD, FACC applied these steps, yielding clear targets matching trigger beat morphology. The steps taken included: - Reviewing Stored ICD Trigger Electrograms (SITE) - Conducting Detailed ILAM and Voltage Map of LV and RV - Induction attempts via pacing and isoproterenol infusion - Real-time pacing mapping through ICD - Ablation of positive pace matches Despite no substrate to target or inducible arrhythmias, great pace matches led to clear ablation targets. Kudos to Dr. Glenn Dym and the team at AdventHealth Celebration, with great mapping from Sarah Charbonneau, CEPS, BSN, and support from Jafet Canaan BSN, RN. Thank you Roderick Tung for sharing the paper. Read more about this in the full paper titled "Empiric ablation of polymorphic ventricular tachycardia/fibrillation in the absence of a mappable trigger: Prospective feasibility and efficacy of pacemap matching to defibrillator electrograms." Also thank you to Babak Nazar, George Crowell and Brock Gambill for developing the PDX Mapping technique utilized during the case. https://lnkd.in/enKPjuVv

How HeartKey® Rhythm can increase clinical workflow efficiencies 📈 In our latest case study, we integrated signal quality indicators from HeartKey Rhythm into the ECG review process at an IDTF to reduce the volume of irrelevant data, ensuring only clinically relevant signals are reviewed. This innovative solution reduced the number of unactionable events requiring manual review by 40.6% and cut the total number of ECG events needing manual review by 17.1%. Our results highlight a significant breakthrough in managing ambulatory ECG data, reinforcing B-Secur's dedication to advancing cardiac monitoring technologies and enhancing clinical workflow efficiency. Read more: https://lnkd.in/dTRNzfKN #HeartHealth #ECG #HealthcareInnovation #HeartKey #CardiologyTech #AmbulatoryECG #BSecur

This study demonstrates the power introducing HeartKey can have on ECG interpretation. Are you ready to upgrade your cardiac diagnostic workflow? Get in touch to find out how easy our technology is to integrate 💚💚

Exploring Cardiogenic Shock Treatment with Multi-Device Simulation #ComputationalLife In our latest breakthrough, we've digitally replicated a patient in the throes of cardiogenic shock to assess the efficacy of four distinct medical devices. Our visual graphs do more than just depict left ventricular volumes during a cardiac cycle – they provide critical insights that guide physicians towards the most impactful treatment options. The evidence is clear and corroborated by literature: pVADs effectively reduce End-Diastolic Volume (EDV) without significantly affecting End-Systolic Volume (ESV). IABP optimally decreases both EDV and ESV, improving cardiac function. LVADs, with their unique triangular volume profiles, substantially reduce the overall volume in the left ventricle. ECMO, specifically from the right atrium to the femoral artery, increases both ESV and EDV. These simulations are more than data – they are the future of personalized patient care, offering a window into the real-time impact of life-saving interventions. Delve into the intricacies of our pioneering research and be part of the conversation shaping the future of cardiac care. For continuous updates and insights, make sure to follow our LinkedIn page. #DigitalHealth #CardiogenicShock #MedicalSimulation #HealthcareInnovation #IABP #pVAD #LVAD #ECMO #CardiacCare

🚨 CMG Update 🚨 The following Clinical Management Guidelines (CMG) have been reviewed and updated: ☑️ Keratitis (CL associated, infiltrative) ☑️ Marginal keratitis ☑️ Photokeratitis ☑️ Cellulitis (pre-septal and orbital) ☑️ Contact lens associated papillary conjunctivitis (CLAPC) ☑️ Endophthalmitis College members can view a summary of the updates made to the CMGs on our website ➡️ https://coptom.uk/CMGs